T cell receptor (TCR) V gene segment use in HLA-typed Japanese healthy subjects

The expression of 13 different α and β V gene segments of the T cell receptor for antigen (TCR) was examined, using V gene-specific MoAbs, on human peripheral blood T lymphocytes from 32 healthy Japanese subjects. In addition, to examine associations between TCR V gene products and HLA alleles, the HLA class I and class II types of all subjects were serologically determined. The reactivities of the anti-TCR V-specific MoAbs were, with some significant exceptions, similar to those previously described in healthy Caucasian subjects. We found a non-random V gene usage as well as a statistically significant bias of the expression of eight Vβ gene products towards the CD4⁺ subpopulation, and a significant skewness in the usage of Vα12 towards the CD8⁺ population. Some subjects showed increased reactivities (above 10%) of certain MoAbs, mainly in the CD8⁺ subpopulation. We found no distinct correlation between any certain HLA class I or II allele and TCR V gene usage in the CD8⁺ or CD4⁺ subpopulations, respectively. In conclusion, the pattern of anti-TCR V-specific MoAb reactivities found in CD4⁺ and CD8⁺ subsets of peripheral blood lymphocytes of healthy Japanese subjects was in general found to match that previously described in healthy Caucasian subjects.     

The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1α, and its interaction with indomethacin

Summary Pre-incubation of human platelets with nifedipine in vitro or treatment of normal volunteers with nifedipine, 30 mg daily for one week, did not alter ADP induced aggregation measured by whole blood aggregometry. 6-oxo-Prostaglandin F₁ remained undetectable in plasma following oral administration of nifedipine to normal volunteers. The hypotensive response to intravenous nifedipine administration was similar in spontaneously hypertensive rats pretreated with indomethacin or placebo. These results conflict with previous reports that nifedipine alters platelet aggregation and prostaglandin metabolism.     

Prevalence and prognostic significance of cardiac arrhythmias detected by ambulatory electrocardiography in subjects 85 years of age

24 hour ambulatory electrocardiography was performed in a representativegroup of people born in 1897. Out of 73 people included in thestudy, 22 were without known heart disease, 15 had definiteischaemic heart disease (IHD) and 36 symptoms of possible cardiacorigin. An R-R interval in excess of 2000 ms was seen in only3 subjects and Wenckebach A-V block in only one. One subjectwithout a history of syncope had a nocturnal episode of completeA-V block with an escape interval of 8000 ms. The most strikingdifference between healthy subjects and patients with IHD wasthe higher number of patients with more than 1000 ventricularpremature beats (VPBs) per 24 hour and ventricular coupletscompared with the number of healthy subjects with such findings.At follow-up two years later 11% had died, with the highestmortality in patients with IHD (33%), and out of 8 patientswith IHD who had more than 1000 VPBs per 24 hour, 4 (50%) haddied compared with only one (14%) of those with less than 1000VPBs. Our results seem to indicate that more than 1000 VPBsper 24 hour is a very unusual finding in healthy 85 year oldindividuals. When it occurs in very old people, it is usuallyin connection with IHD, and in this setting it signifies a poorprognosis.     

Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

Summary Milrinone, a new, nonglycosidic inotropic agent with peripheral vasodilating properties, was given as a single oral 5 mg dose to 7 healthy subjects, 7 patients with moderate renal impairment (CRI I, creatinine clearance 30–63 ml/min) and 7 patients with severe renal impairment (CRI II, creatinine clearance 9–29 ml/min). All except one of the patients with renal impairment had hypertension. The mean urinary recovery of milrinone was 82% in healthy subjects, the renal clearance was 288 ml/min and the plasma half-life (t_1/2) was 0.94 h. In CRI the mean plasma t_1/2 was prolonged (CRI I 1.78 h, CRI II 3.24 h). There was a significant linear relationship between creatinine clearance and the elimination rate constant, and between creatinine clearance and the renal clearance of milrinone. During the study day there was a tendency to a decrease in supine BP from 1 to 6–8 h after dosing, with the maximal decrease at 2–3 h (healthy subjects 118/71107/56, CRI 159/95136/79 mmHg). The same degree of change was seen in standing BP. A slight rise in standing HR was seen from 2–6 h after dosing. Changes in BP and HR are difficult to evaluate since the study was not placebo-controlled.The plasma elimination rate of milrinone was decreased in CRI and dose adjustment may be necessary. Placebo-controlled studies of milrinone in hypertensive patients would be required to validate its possible antihypertensive effect.     

Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F_{1\alpha }

Summary Fenflumizole (2-(2,4-difluorophenyl)-4,5-bis(4-methoxyphenyl)imidazole), a new non-steroidal anti-inflammatory drug, was given to healthy subjects in single oral doses of 0.1, 1 and 2 mg/kg. The effect of the drug was followed for up to 8 h by repeated tests of arachidonic acid-induced platelet aggregation and was related to its concomitant plasma concentration. Fenflumizole reversibly inhibited platelet aggregation and the degree of inhibition was found to be linearly correlated with the log plasma concentration. There was depression of the formation of thromboxane B₂ and 6-keto-prostaglandin F₁ (the stable metabolites of thromboxane A₂ and prostacyclin) in clotted whole blood measured by radioimmunoassay after fenflumizole 1 mg/kg. This effect was directly related to the concentration of the drug in plasma, the maximum effect being reached at fenflumizole concentrations >200 ng/ml. EC₅₀-values for inhibition of the formation of thromboxane B₂ and 6-keto-prostaglandin were approximately 20 and 40 ng/ml, respectively. The results suggest that orally administered fenflumizole is a potent inhibitor of platelet aggregation and prostanoid formation.     

对我国城市健康养老评价指标体系的分析与思考

[目的]通过对《全球老年友好城市建设指南》(简称《指南》)和《“健康中国2030”规划纲要》(简称《纲要》)中的指标体系以及国内与城市健康养老评价指标体系相关的文献及资料进行分析、归纳和总结,为构建一套既符合国际标准又适应中国国情的城市健康养老评价指标体系提供借鉴。[方法]采用“老年友好城市、健康城市、康养城市、长寿之乡、指标”等作为关键词,基于中国知网、万方数据库,以及政府官网和国家卫生健康委员会网站等,搜索国内与城市健康养老评价指标相关的文献和资料。[结果]《指南》和《纲要》中的指标均涉及健康生活、健康服务和健康环境3个方面;同时,二者也存在一定的差异:《指南》侧重于从微观角度评价老年人群的住、行、环境、社会参与、尊重和包容、就业、信息交流和健康服务等8个方面;《纲要》则侧重于从宏观角度评价全体人群的健康水平、健康生活、健康服务与保障、健康环境和健康产业等5个方面。同时,通过对纳入的21篇文献的分析可知,我国有关老年友好城市评价指标体系构建的研究相对较少,尚未在全国范围内建立起一套系统完整的指标体系;现有的健康城市、康养城市和长寿之乡指标体系均基于我国国情构建,可以借鉴其中城市健康和养老方面的相关指标。[结论]未来在构建城市健康养老评价指标体系时,应以《指南》和《纲要》为指导,并结合我国既有的相关指标体系,该指标体系应该是科学全面的、既与国际接轨又符合中国国情需要的城市健康养老评价指标体系。     

2005—2020年盐城市丙型病毒性肝炎的流行病学特征分析

目的 分析2005—2020年盐城市丙肝病例报告资料,总结丙肝流行特征,为盐城市丙肝防制工作提供参考依据。方法 收集各年度丙肝报告病例和人口学资料,采用Excel 2016软件汇总并作描述性统计分析。采用Joinpoint regression program（JRP）4.9.0.0软件对丙肝年发病率进行趋势检验,采用SPSS 25.0软件和ArcGIS 10.6软件对病例数据进行统计分析。结果 2005—2020年盐城市累计报告丙肝病例2 555例,年报告发病率整体呈平缓增长趋势,最低为2005年的0.42/10万,最高为2019年的5.84/10万。年度变化百分比(annual percent change,APC)为14.5% （95% CI: 11.5%~17.6%）,P<0.01。除2019年外,其余各年丙肝疫情呈散发状态,无明显季节特征。报告病例数位居前三位的地区是亭湖区、滨海县以及东台市,分别占比19.77% （505/2 555）、14.01%（358/2 555）以及12.92%（330/2 555）。男女报告病例数比为1.33[DK]∶1,发病率最高的年龄组为70~79岁年龄组（56.94/10万）。农民为报告病例数最多的人群,占比59.33%（1 516/2 555）。确诊病例2 204例,临床诊断病例332例。结论 盐城市丙肝疫情呈上升趋势。全市应进一步扩大丙型肝炎病毒检测,加强丙肝防治宣传教育和完善社会医疗保障政策来提高丙肝治疗的可及性和可负担性,同时应进一步加强对于丙肝疫情的监测以及规范丙肝的诊疗,并对重点地区、重点人群开展精准的综合干预工作。     

科技期刊邮件推送的用户调研与策略分析

【目的】 从读者和期刊两方面进行调研,对比分析科技期刊通过邮件推送进行宣传,从而促进学术成果有效传播,增强用户黏性的策略,为我国科技期刊宣传提供参考。【方法】 通过问卷调查、实例调研、案例分析及对比,分析不同做法对邮件推送结果的影响,给出优化的方法和建议。【结果】 问卷调研结果反映的用户需求与同行期刊和中国激光杂志社邮件推送实例的分析结果相互印证。科技期刊在进行邮件推送时,要先了解邮件推送目标用户的需求,并根据需求对邮件推送活动进行合理优化。【结论】 精准性是邮件推送工作首先要考虑的因素;合适的主题、时效性强、恰当的推送频率也是推送工作需注意的要素。     

基于“正虚邪滞”理论探讨肺癌自噬机制及中药干预进展

自噬是一种细胞自我保护和自我更新机制,与肺癌的发生发展密切相关,有利自噬可以减缓肺癌进展,而不利自噬能够促进肺癌进展,故调节自噬水平在肺癌治疗中具有重要意义。“正虚邪滞”是王永炎院士“虚气留滞”理论的延伸,是指因肺脾肾气亏虚,引发津液代谢异常,导致痰瘀阻滞的病理过程,以肺脾肾气亏虚为本、痰瘀阻滞为标,是肺癌的关键病机。肺癌的自噬机制与“正虚邪滞”有着相互贯通之处,肺脾肾气亏虚是肺癌有利自噬减弱的关键因素,进而抑制了肿瘤细胞凋亡,并导致有害物质蓄积;痰瘀阻滞是肺癌不利自噬增强的直接因素,进而促进了正常细胞自噬性死亡,削弱了免疫细胞对肿瘤细胞的免疫抑制作用,导致肿瘤细胞增殖和迁移。正虚与邪滞相合,致使自噬状态向着不利的方向不断发展,最终导致肺癌持续进展。因此,中医干预肺癌自噬机制需以扶正抗邪为原则,补益正气以治其本,祛痰化瘀以治其标,增强有利自噬的同时抑制不利自噬,将自噬水平调节到最佳状态,从而抑制肿瘤细胞增殖和迁移,促进肺癌的缓解。通过分析现有文献可知,目前通过自噬途径治疗肺癌的中医药以中药单体为主,中医药干预肺癌自噬的作用主要集中在促进自噬激活层面,这可能是因为藉由肺脾肾气亏虚引发的有利自噬减弱是肺癌发展的根本原因。     

Three-Year Follow-Up of the POIBA Intervention on Childhood Obesity: A Quasi-Experimental Study

Childhood obesity has increased worldwide over the past four decades. This quasi-experimental study aimed to assess the effectiveness of a multicomponent and multilevel school-based intervention (POIBA) at 3 years of follow-up. The nutrition intervention focused on food groups, food pyramid, nutrients, portions, and balanced menus. In total, 3624 children participated in the study. Anthropometric measurements and information on food frequency and behavior, physical activity, and daily screen use were collected in the intervention (IG) and comparison group (CG). Positive unadjusted changes toward adherence to recommendations were found for water, meat, sweets, and fried potato consumption, proper breakfast, not having dinner in front of the TV, out-of-school physical activity, and daily screen use. Three scores were used to calculate the proportion of children making more than one change to improve healthy habits regarding physical activity (global Activity score), nutrition (global Nutrition score), and both (global score). Students exposed to the intervention had a significantly better global Activity score (16.2% IG vs. 11.9% CG; p = 0.012) and Global score (63.9% IG vs. 58.5% CG; p = 0.025). Intervention effects on obesity incidence at 3-year follow-up lost significance but maintained the positive trend. In conclusion, school-based interventions including a family component could be useful to address the childhood obesity problem.